Clever Leaves Granted Good Agricultural and Collecting Practices (GACP) Certification
BOGOTÁ, Colombia, June 04, 2020 (GLOBE NEWSWIRE) — Clever Leaves (the “Company”), a leading multi-national operator (MNO) and licensed producer of pharmaceutical-grade medical cannabis and hemp extracts, has been granted Good Agricultural and Collecting Practices (GACP) Certification by the CUMCS (Control Union Medical Cannabis Standard), after meeting the CUMCS’ guidelines for quality and consistency in the cultivation and harvest of medical cannabis. The new certification further enables Clever Leaves to export pharmaceutical-grade cannabis products to international markets.
CUMCS standards provide general technical guidance on obtaining high-quality medicinal plant materials for the sustainable production of herbal products classified as medicinal products. CUMCS, designed to ensure top quality product and consistency in production, is a renowned global standard for medical cannabis certification. The certification by CUMCS validates Clever Leaves’ standardized practices and procedures throughout the agricultural and collecting process. It also required review and approval of Clever Leaves’ trained personnel practices, use of qualified equipment, and documentation and approval procedures. In addition, the certification attests that the Company operates under procedures to produce crops that are free of heavy metals and agrochemicals and protocols for biodiversity safety in pharmaceutical manufacturing.
“GACP certification reflects Clever Leaves’ ability to produce pharmaceutical-grade cannabis as well as our adherence to stringent operational standards. Achieving internationally-recognized quality guidelines will enable us to bring value at every touch point of the supply chain,” said Kyle Detwiler, CEO of Clever Leaves.
“Clever Leaves has once again proven the quality of its operation and the rigor of its procedures, highlighting the talent and dedication of a multidisciplinary and highly trained team. Patients around the world can be confident that Clever Leaves raw materials meet internationally-recognized standards for freedom from heavy metals or agrochemicals,” said Andres Fajardo, President of Clever Leaves.
Control Union Certifications, a Dutch based leading worldwide certification body, is a global leader in medical cannabis certification. The CUMCS certification standard is based on GACP guidelines of The World Health Organization (WHO), the GACP Guidelines of the European Medicines Agency, Guidelines of the Dutch Government for Cannabis for Medical Use, and the International Standard for Good Agriculture Practice. CUMCS certified cultivation sites are compliant with these GACP Guidelines. CUMCS examines the consistency of medicinal plants and the quality of process for propagation, growing, cultivation, drying and packaging, among other areas.
Source: Clever Leaves via Globe Newswire
For further information, please contact:
SENSO Communications
Penny Lukats, 07775992350, penny@sensocommunications.com
For more information on the EUMCA (www.eumca.org) and membership, please contact:
Sita Schubert, General Secretary of the EUMCA on +32 233 90 281, info@eumca.org
NOTES TO EDITORS
The EUMCA is the first international non-profit association governed by the provisions of the Belgian Code des Sociétés et des Associations. Its membership is a multi-stakeholder network representing the interests of a wide range of organisations operating in the research and development, production and/or distribution of medical cannabis-based treatments.
The EUMCA’s mission is to improve the life and health outcomes of patients across Europe, by promoting the development of national government healthcare policies that advocate i) the ethical prescription of pharmaceutical-grade medicinal cannabis, and ii) advance patient access to treatments. It does this through:
- Research & Development: Promoting scientific medical research and policy to support the standardised, ethical and sustainable use of medicinal cannabis.
- Patient Access & Reimbursement: Working with national reimbursement institutions to improve patient access to medical cannabis-based treatments.
- Medical Education: Providing evidence-based knowledge and learning on medicinal cannabis to healthcare professionals and patients.
- Legal & Compliance: Consulting with governments where ongoing or urgent action is necessary.
- Regulatory & Quality: Providing members with counsel and guidance on regulatory affairs.
- Business Development: Delivering networking opportunities for members focused on building their business through M&A, licensing, partnering and novel in-market strategies.